Richard Klasa

11.2k total citations · 2 hit papers
104 papers, 7.5k citations indexed

About

Richard Klasa is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Richard Klasa has authored 104 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Pathology and Forensic Medicine, 57 papers in Oncology and 39 papers in Genetics. Recurrent topics in Richard Klasa's work include Lymphoma Diagnosis and Treatment (90 papers), Viral-associated cancers and disorders (39 papers) and Chronic Lymphocytic Leukemia Research (37 papers). Richard Klasa is often cited by papers focused on Lymphoma Diagnosis and Treatment (90 papers), Viral-associated cancers and disorders (39 papers) and Chronic Lymphocytic Leukemia Research (37 papers). Richard Klasa collaborates with scholars based in Canada, United States and Netherlands. Richard Klasa's co-authors include Randy D. Gascoyne, Joseph M. Connors, Laurie H. Sehn, Kerry J. Savage, Mukesh Chhanabhai, Karamjit Gill, Tamara Shenkier, Paul Hoskins, Douglas E. Horsman and Judy Sutherland and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Richard Klasa

103 papers receiving 7.3k citations

Hit Papers

The revised International Prognostic Index (R-IPI) is a b... 2005 2026 2012 2019 2006 2005 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
    2006 1.0k citations Laurie H. Sehn, Mukesh Chhanabhai et al. Blood profile →
  2. Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia
    2005 744 citations Laurie H. Sehn, Mukesh Chhanabhai et al. Journal of Clinical Oncology profile →

Peers

Richard Klasa
Marek Trněný Czechia
Éric Van Den Neste Belgium
Mukesh Chhanabhai Canada
Sonali M. Smith United States
Michelle A. Fanale United States
Ivana N. Micallef United States
Francesc Bosch Spain
Tamara Shenkier Canada
Vincent Ribrag France
Morton Coleman United States
Marek Trněný Czechia
Richard Klasa
Citations per year, relative to Richard Klasa Richard Klasa (= 1×) peers Marek Trněný

Countries citing papers authored by Richard Klasa

Since Specialization
Citations

This map shows the geographic impact of Richard Klasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Klasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Klasa more than expected).

Fields of papers citing papers by Richard Klasa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Klasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Klasa. The network helps show where Richard Klasa may publish in the future.

Co-authorship network of co-authors of Richard Klasa

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Klasa. A scholar is included among the top collaborators of Richard Klasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Klasa. Richard Klasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hitz, Felicitas, Joseph M. Connors, Randy D. Gascoyne, et al.. (2015). Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment. Annals of Hematology. 94(11). 1839–1843. 54 indexed citations
2.
Mak, Vivien, Mukesh Chhanabhai, Tamara Shenkier, et al.. (2013). Survival of Patients With Peripheral T-Cell Lymphoma After First Relapse or Progression: Spectrum of Disease and Rare Long-Term Survivors. Journal of Clinical Oncology. 31(16). 1970–1976. 286 indexed citations
3.
Connors, Joseph M., Laurie H. Sehn, Diego Villa, et al.. (2013). Gemcitabine, Dexamethasone, and Cisplatin (GDP) As Secondary Chemotherapy In Relapsed/Refractory Peripheral T-Cell Lymphoma. Blood. 122(21). 4345–4345. 3 indexed citations
4.
5.
Johnson, Nathalie A., Kerry J. Savage, Olga Ludkovski, et al.. (2009). Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood. 114(11). 2273–2279. 414 indexed citations
6.
Chiu, Gigi N.C., Lincoln Edwards, Anita I. Kapanen, et al.. (2007). Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructs. Molecular Cancer Therapeutics. 6(3). 844–855. 51 indexed citations
7.
Belch, Andrew R., C. Tom Kouroukis, Michael Crump, et al.. (2006). A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150. Annals of Oncology. 18(1). 116–121. 126 indexed citations
8.
Waterhouse, Dawn, Richard Klasa, Euan Ramsay, et al.. (2006). Development and Assessment of Conventional and Targeted Drug Combinations for Use in the Treatment of Aggressive Breast Cancers. Current Cancer Drug Targets. 6(6). 455–489. 32 indexed citations
9.
Farinha, Pedro, Hamid Masoudi, Brian Skinnider, et al.. (2005). Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood. 106(6). 2169–2174. 376 indexed citations
10.
Bebb, Gwyn, Richard Klasa, Mukesh Chhanabhai, et al.. (2005). Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma. Leukemia Research. 30(4). 449–457. 27 indexed citations
11.
Okamoto, Ichiro, Valia S. Lestou, Olga Ludkovski, et al.. (2004). Delineation of a minimal region of deletion at 6q16.3 in follicular lymphoma and construction of a bacterial artificial chromosome contig spanning a 6‐megabase region of 6q16–q21. Genes Chromosomes and Cancer. 40(1). 60–65. 20 indexed citations
12.
Au, Wing Y., Douglas E. Horsman, Randy D. Gascoyne, et al.. (2003). The Spectrum of Lymphoma with 8q24 Aberrations: A Clinical, Pathological and Cytogenetic Study of 87 Consecutive Cases. Leukemia & lymphoma. 45(3). 519–528. 49 indexed citations
13.
Wasan, Ellen K., Dawn Waterhouse, Olena Sivak, et al.. (2002). Plasma protein binding, lipoprotein distribution and uptake of free and lipid-associated BCL-2 antisense oligodeoxynucleotides (G3139) in human melanoma cells. International Journal of Pharmaceutics. 241(1). 57–64. 9 indexed citations
14.
Au, W.Y., Doug Horsman, Hitoshi Ohno, Richard Klasa, & Randy D. Gascoyne. (2002). Bcl-3/IgH translocation (14;19)(q32;q13) in Non-Hodgkin's Lymphomas. Leukemia & lymphoma. 43(4). 813–816. 26 indexed citations
15.
Au, Wing Y., Randy D. Gascoyne, David S. Viswanatha, et al.. (2002). Cytogenetic Analysis in Mantle Cell Lymphoma: A Review of 214 Cases. Leukemia & lymphoma. 43(4). 783–791. 36 indexed citations
16.
Goss, Paul E., A. Keith Stewart, Félix Couture, et al.. (1999). Combined Results of Two Phase Il Studies of Taxol (Paclitaxel) in Patients with Relapsed or Refractory Lymphomas. Leukemia & lymphoma. 34(3-4). 295–304. 13 indexed citations
17.
Connors, Joseph M. & Richard Klasa. (1998). Treatment of follicular lymphoma. Current Opinion in Oncology. 10(5). 392–395. 2 indexed citations
18.
OʼReilly, Sean, et al.. (1993). In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy.. Journal of Clinical Oncology. 11(11). 2250–2257. 74 indexed citations
19.
Klasa, Richard, Nevin Murray, & A. J. Coldman. (1991). Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung.. Journal of Clinical Oncology. 9(3). 499–508. 106 indexed citations
20.
Klasa, Richard, et al.. (1988). Goodpasture's syndrome: Recurrence after a five-year remission. The American Journal of Medicine. 84(4). 751–755. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marek Trněný Breakdown of academic impact, for papers by Éric Van Den Neste Breakdown of academic impact, for papers by Mukesh Chhanabhai Breakdown of academic impact, for papers by Sonali M. Smith Breakdown of academic impact, for papers by Michelle A. Fanale Breakdown of academic impact, for papers by Ivana N. Micallef Breakdown of academic impact, for papers by Francesc Bosch Breakdown of academic impact, for papers by Tamara Shenkier Breakdown of academic impact, for papers by Vincent Ribrag Breakdown of academic impact, for papers by Morton Coleman
Rankless by CCL
2026